HSPiP, Computational Modeling, and QbD-Assisted Optimized Method Validation of 5-Fluorouracil for Transdermal Products.
Autor: | Hussain A; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Ramzan M; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India., Altamimi MA; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia., Khuroo T; Department of Pharmaceutics, PGx Global Foundation, 5600 S, Willow Dr Houston, Houston, Texas 77035, United States., Mohd Siddique MU; Department of Pharmaceutical Chemistry, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India., Alnemer OA; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. |
---|---|
Jazyk: | angličtina |
Zdroj: | ACS omega [ACS Omega] 2023 Dec 22; Vol. 9 (1), pp. 903-916. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2024). |
DOI: | 10.1021/acsomega.3c07061 |
Abstrakt: | This study addressed the simplest and most efficient HPLC (high-performance liquid chromatography) method for the estimation of 5-fluorouracil (5-FU) from rat blood plasma by implementing the Hansen solubility parameters (HSP), computation prediction program, and QbD (quality by design) tool. The mobile phase selection was based on the HSP predictions and experimental data. The Taguchi model identified seven variables (preoptimization) to screen two factors (mobile phase ratio as A and column temperature as B) at three levels as input parameters in "CCD (central composite design)" optimization (retention time as Y Competing Interests: The authors declare no competing financial interest. (© 2023 The Authors. Published by American Chemical Society.) |
Databáze: | MEDLINE |
Externí odkaz: |